“The partnership with Tydliga is an important step for us at Virtune. It gives us the opportunity to reach a broader customer base through Tydliga's extensive network of professional advisors and ...

Clinical validation of the Azymetric platform is demonstrated by the accelerated approval of Ziihera® (zanidatamab-hrii), a treatment for advanced HER2-positive biliary tract cancer in adults who have ...

Nowadays MROpen Evo is available in USA, Canada, UK, Italy, Portugal, Kuwait, and the innovative MgB2 superconducting technology – the key element driving the unique and distinctive open design - has ...

Quantum Trilogy’s approach enables clients to operate securely, and efficiently in dynamic and complex environments and anticipate future challenges. Its trusted network, innovative technology, ...

The two indexes — featured in the 2025 edition of the annual Investment Migration Programs  report — offer a systematic analysis and comprehensive benchmarking of the world’s most attractive ...

The proposed amendments to the terms of the 2025 convertible bond have been approved by the bondholders and will become binding and effective upon approval by the higher cantonal composition authority ...

Skyharbour is fully-funded for its upcoming drill programs at its co-flagship Russell Lake and Moore Uranium Projects in 2025 starting with this first phase of drilling at Russell. The Company has ...

BOSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Anaqua , a leading provider of innovation and intellectual property (IP) management technology solutions and services, today announced that Nordic Capital , ...

The next major OpenCloud release in March 2025 will include the launch of various enterprise services such as support packages for enterprise customers. This release will also mark the official launch ...

ZenaDrone previously completed paid trials with both the US Air Force and the US Navy using its drones for carrying critical cargo — such as blood — in the field. ZenaDrone plans to manufacture and ...

Camposol Achieves Record EBITDA of USD 184.1 million in 2024, and a Net Debt to EBITDA ratio of 2.41x, Highlighting Market Leadership in Key Exports and Financial Discipline. 1) Full year 2024 ...

EVX-01 is designed with Evaxion’s AI-Immunology™ platform and tailored to target the unique tumor profile and immune characteristics of each individual patient. It engages the patient's immune system ...